Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

The introduction in 1998 of imatinib mesylate (IM) revolutionized management of patients with chronic myeloid leukemia (CML) and the second generation of tyrosine kinase inhibitors may prove superior to IM. Real-time quantitative polymerase chain reaction (RQ-PCR) provides an accurate measure of the...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Hughes, Timothy, Deininger, Michael, Hochhaus, Andreas, Branford, Susan, Radich, Jerald, Kaeda, Jaspal, Baccarani, Michele, Cortes, Jorge, Cross, Nicholas C. P., Druker, Brian J., Gabert, Jean, Grimwade, David, Hehlmann, Rüdiger, Kamel-Reid, Suzanne, Lipton, Jeffrey H., Longtine, Janina, Martinelli, Giovanni, Saglio, Giuseppe, Soverini, Simona, Stock, Wendy, Goldman, John M.
格式: Artigo
語言:Inglês
出版: The American Society of Hematology 2006
主題:
Review in Translational Hematology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895821/
https://ncbi.nlm.nih.gov/pubmed/16522812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-01-0092
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍